Insightec

Valuation $3B

About Insightec

InSightec develops and manufactures MR-guided ultrasound technology devices for image-guided acoustic surgery.
Headquarters Insightec, Tirat Carmel
Founded 1999-01-01
Industry Biotechnology, Health Care, Manufacturing, Medical Device, Therapeutics
Last Funding Type Private Equity
Valuation 3
Total Funding $882.90 million dollars
IPO Status Private

Financial

InSightec announced the availability of Exablate Prime, the next generation of MR-guided focused ultrasound, in Europe. Additionally, InSightec raised $150 million to enhance the therapeutic capabilities of its focused ultrasound technology.

INSIGHTEC Ltd. is focused on advancing MR-guided ultrasound technology for non-invasive surgeries. Their research includes systems for controlling drug delivery through tissue barriers, such as the blood-brain barrier, by using ultrasound to increase permeability. They are developing methods for image registration across different modalities, adhesive compositions for high-voltage ultrasound applications, and techniques for monitoring tissue permeability. Additionally, they are exploring conformal phased-array transducer arrangements, short-pulse sonodynamic treatment, and effective delivery of monoclonal antibodies. Their work also encompasses ultrasound autofocusing, variable-bandwidth transducers, and diagnostic technologies related to blood-brain barrier disruption. Each area aims to enhance precision and effectiveness in image-guided acoustic surgery.

InSightec, a healthcare company specializing in focused ultrasound technology, announced it has raised $150 million in equity financing. The funds will support the continued growth and development of its incision-less, ultrasound-based neurosurgery technology.
Funding Rounds 12
Number of Lead Investors 7
Total Funding Amount  $882.90 million dollars
Number of Investors 20

Related Angels

Daniel Cotlar
View profile
Amos Ben-Meir
View profile